Fortune News | Jan 05,2020
May 31 , 2020
By Fisseha Shiferie ( Fisseha Shiferie is a public health expert and pharmacist. He can be reached at email@example.com. )
The United Nations has declared access to “safe, effective, quality, and affordable essential medicines” to be one of the Sustainable Development Goals (SDGs) of their 2030 Agenda. Still, substandard and falsified (SF) medical products represent a serious problem for public health, especially in Africa, Southeast Asia and Latin America.
Substandard medical products can be defined as “authorised medical products that fail to meet either their quality standards or specification, or both,” according to the World Health Organisation (WHO) and may result through poor manufacturing, shipping or storage conditions, or when the drug is sold beyond the expiration date. Falsified medicines, on the other hand, are medical products that deliberately misrepresent their identity, composition or source.
Risks posed by SF medical products can be broadly categorised as health and economic consequences. Health-related consequences of SF medicines include, but are not limited to, risks of morbidity and mortality (resulting from either treatment failure or adverse drug reactions), drug resistance and erosion of patients’ trust in the healthcare system, health care providers and genuine drug manufacturers. By the same token, its economic consequences include increased costs for patients and governments, reduced economic productivity and poverty.
The Novel Coronavirus (COVID-19) is the third coronavirus infection in two decades that was originally described in Asia, after Severe Acute Respiratory Syndrome (SARS) and the Middle East Respiratory syndrome (MERS). There are currently over five million confirmed cases and over 345,000 have died from the virus worldwide. In Ethiopia, the total number of confirmed cases is in the hundreds, while the number of those that have died from the virus, fortunately, stands in the single digits.
COVID-19 and substandard and falsified medicines share one thing in common: both are global public health threats. However, COVID-19 and SF products are different in many fundamental ways. Obviously, COVID-19 is a disease, but the latter is not. While COVID-19 is spreading across both developed and developing nations, the profound impact of SF medical products is more pronounced in low- and middle-income countries, including Ethiopia. It is estimated that 10pc of medical products in developing countries are SF, according to the WHO. Due to the current increased demand for medicines, vaccines and reagents following the pandemic, this prevalence will increase.
COVID-19 might increase the demand and consumption of SF medical products in three major ways.
The first way is due to the inability of a vulnerable segment of the population - pregnant women, individuals working in the informal sector, and patients with comorbidities - to access healthcare services.
As a way of curbing the transmission of the virus and preventing its devastating consequences, the Ethiopian government declared a five-month state of emergency (SOE). As part of the SOE, stay-at-home or work-from-home orders were issued. Businesses, schools and universities are closed. Transportation fares have doubled as compensation for the 50pc reduction of passenger loads.
With the stay-at-home orders and increased tariffs, millions of individuals might face unprecedented difficulties to access healthcare services. Essential medicines are one of them. It is during this time that these people get exposed to SF medical products.
The inevitable consequences of SF medical products are not only limited to people working in the informal sector. It also affects the other vulnerable segments of the population such as people living with HIV/AIDS, patients with comorbidities, communities living in malaria-endemic settings, pregnant women and people under treatment for tuberculosis.
It is inevitable that the pandemic would take attention away from routine health care services. Pregnant women, for example, are expected to visit health facilities as frequently as possible. With the pandemic taking the air out of the attention from other health services, women and their babies’ health will definitely be at high risk. This will open the door for ill-intended SF dealers to easily distribute their products. The risk posed to the remaining vulnerable segment of the population is no different.
The other way for people to get exposed to SF medical products is due to fear of being quarantined, isolated and traced. Quarantine of suspected cases and isolation of COVID-19 patients and contact tracing are the strategies being implemented to contain the spread of the virus. The acceptability of these measures by the community has not been encouraging though. Fear of being quarantined and isolated might force people to use whatever is available in the market as a substitute for visiting healthcare facilities. In this regard, the chances of accessing SF medical products is very high.
Yet another way is related to import permits for medical products. Since the first case was reported in Ethiopia back in March 2020, an overwhelming number of applications from medicine and medical supplies importers are being filed.
The government has given priority and incentives to importers that have submitted applications to import COVID-19 related medical supplies such as face masks, hand sanitiser and gloves. This is a good and timely decision in terms of filling the PPE shortage we are facing.
In a country like Ethiopia, where there is an already existing shortage of essential medicines, the tight window through which these products are allowed to come in is tantamount to adding fuel to the fire. It complicates the problem and will be a good recipe for dealers of SF medical products to easily penetrate the market.
The threat from SF medical products will continue even after the COVID-19 era unless strict steps are taken by the government. Genuine importers, healthcare providers and end-users should be vigilant in the war against SF medical product dealers.
One way of overcoming such threats, especially for consumers, is by following certain general guidelines that can go a long way in combatting the flood of SF medicines.
People need to look at the packaging and search for spelling mistakes and grammatical errors. Checking who the manufacturer is and whether or not the expiry date matches the inner package would also go a long way. Discussing the products with healthcare providers by any available means is critical, as is reporting suspicious medicines to the authorities.
Although the measures that are being taken to halt the transmission of COVID-19 are timely and appropriate, it is also highly important to consider the underemployed and the vulnerable segments of society. They need to be protected both from the pandemic and the consequences of these control measures, consumption of SF medical products in this case. Concerned regulatory bodies should intervene aggressively to ensure the safety, quality and effectiveness of medical products before we face a parallel pandemic of substandard or falsified alternatives.
PUBLISHED ON May 31,2020 [ VOL 21 , NO 1049]
Fortune News | Jan 05,2020
Fortune News | Feb 16,2019
Commentaries | Nov 21,2020
Fortune News | Jul 13,2019
Viewpoints | Apr 10,2021
Fortune News | 37039 Views | Jul 18,2020
Fortune News | 16451 Views | Oct 12,2019
Exclusive Interviews | 15257 Views | Aug 10,2019
Fortune News | 15240 Views | Mar 19,2020
March 27 , 2021 . By BAMLAK FIKADU
An application developer who has recently taken up hiking to get some exercise, Migno...
February 13 , 2021 . By TADESSE TSEGAYE
In Arada, I stopped over by a hotel in front of Cinema Empire. I sat alone inside wit...
January 30 , 2021 . By FASIKA TADESSE
The Council of Ministers approved a regulation that will establish the Liability &...
January 16 , 2021
It was a sunny day on September 12, 1974. A machine gun mounted on top of a tank was...
Economic and political development go hand in hand with a good educational system. Th...
Leaders of the National Election Board are in a charm offensive mood, of a sort. Last week, they organised a rare tour for members of the me...
When the country’s most senior diplomats and envoys return back to their posts after two-week debriefings, they leave behind a point or tw...
April 10 , 2021
It is not often the case for regional states' leaders to swallow their vanity and dec...
April 3 , 2021
As an Auditor General, he was not the most conspicous of officials in the mainstream...
March 27 , 2021
In an unprecedented turn of irony, just as Ethiopia began an attempt to open up to th...
March 20 , 2021
There is never a dull moment in the tense and combative relationship between regulato...
PM Abiy Ahmed (PhD) at a Gala Dinner Called for the Awarding of the Félix Houphouët-Boigny Peace Prize
May 6 , 2019
Do not judge a book by its cover, we say. But we still judge all the same. It is much worse when it comes to a living, breathing person. We...
April 10 , 2021
Jemal Ahmed (left), CEO of MIDROC Investment Group, hands Adanech Abiebie (centre), deputy mayor of Addis Abeba, the city that is home to a...
April 10 , 2021 . By NEJAT AHMED
Ethiopia is spending 27.2 billion Br (over 660 million dollars in the current exchange rate) on importing...
Companies operating in the country's industrial parks have raised concerns with the central bank's recent...
April 10 , 2021 . By NEJAT AHMED
Half-a-dozen private higher learning institutions have been subject to regulatory action from the federal...
Or see contact page